Satisfaction and attitudes toward systemic treatments for psoriasis: A cross‐sectional study-Reference-Cited by-同舟云学术

Satisfaction and attitudes toward systemic treatments for psoriasis: A cross‐sectional study

Published:2021-03-25 Issue:3 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Esposito Maria¹^ORCID,Giunta Alessandro²,Gisondi Paolo³^ORCID,Tambone Sara⁴,Rovaris Marco³,Manfreda Valeria²^ORCID,Pirro Federico⁵,Pellegrini Cristina¹,Fargnoli Maria Concetta¹,Bianchi Luca²,Peris Ketty⁴⁵,Girolomoni Giampiero³

Affiliation:

1. Dermatology Unit, Department of Biotechnological and Applied Clinical Sciences University of L'Aquila L'Aquila Italy

2. Department of Dermatology University of Rome “Tor Vergata” Rome Italy

3. Department of Medicine, Section of Dermatology and Venereology University of Verona Verona Italy

4. UOC di Dermatologia Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy

5. Università Cattolica del Sacro Cuore Rome Italy

Funder

Pfizer

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.14949

Reference22 articles.

1. State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis

2. Comparison of Biologics and Oral Treatments for Plaque Psoriasis

3. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review

4. A Canadian online survey to evaluate awareness and treatment satisfaction in individuals with moderate to severe plaque psoriasis

5. Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation;Rheumatology and Immunology Research;2024-03-01

2. IL-17 and -23 Inhibitors for the Treatment of Psoriasis;EMJ Allergy & Immunology;2023-04-12

3. Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study;Journal of Dermatological Science;2022-03

4. Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records;Dermatology and Therapy;2021-08-28